874163-20-9 Usage
Molecular structure
1-Pyrrolidinecarboxylic acid, 2-[[[(3R)-1-[2-[[2-[(4-azidobenzoyl)amino]ethyl]amino]-2-oxoethyl]-2-oxo-3-pyrrolidinyl]amino]carbonyl]-, 1,1-dimethylethyl ester, (2S)is a complex molecule with a pyrrolidine ring, a tert-butyl ester group, and an azidobenzoyl group attached to it.
Functional groups
The compound contains several functional groups, including a carboxylic acid group, an ester group, an amino group, and an azide group.
Chirality
The compound has a chiral center at the 2-position of the pyrrolidine ring, with the (2S) configuration indicating the presence of a clockwise arrangement of the substituents.
Potential pharmaceutical applications
Due to its complex structure and the presence of various functional groups, this compound may have inhibitory or modulatory effects on enzymes or protein-protein interactions. This makes it a potential candidate for drug development targeting specific molecular pathways.
Need for further research
To fully understand the biochemical and pharmacological properties of this compound, additional research is required. This includes studying its interactions with biological targets, potential therapeutic effects, and possible side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 874163-20-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,1,6 and 3 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 874163-20:
(8*8)+(7*7)+(6*4)+(5*1)+(4*6)+(3*3)+(2*2)+(1*0)=179
179 % 10 = 9
So 874163-20-9 is a valid CAS Registry Number.
874163-20-9Relevant articles and documents
Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor
Fisher, Abigail,Mann, Amandeep,Verma, Vaneeta,Thomas, Nancy,Mishra, Ram K.,Johnson, Rodney L.
, p. 307 - 317 (2007/10/03)
Pro-Leu-Gly-NH2 (PLG), in addition to its endocrine effects, possesses the ability to modulate dopamine 02 receptors within the central nervous system. However, the precise binding site of PLG is unknown. Potential photoaffinity-labeling ligand